Horse Deworming in 2026: Why the Old Rotation Schedule Is Outdated

How We Got Here: The Rotational Deworming Mistake

For decades, the standard advice was simple: rotate through different drug classes every 6 to 8 weeks, treat every horse on the property on the same schedule, and parasites would never be a problem. It seemed logical. It was, unfortunately, wrong — and we are now living with the consequences.

Anthelmintic resistance in equine parasites is a genuine crisis. Studies across the United States, Europe, and Australia have documented widespread resistance to benzimidazoles (fenbendazole and oxibendazole) in cyathostomins — the small strongyles — and increasing resistance to pyrantel. The mechanism is straightforward: when you treat every horse every 6 to 8 weeks regardless of parasite burden, you apply constant selection pressure on the parasite population. The small percentage of worms that carry resistance genes survive, reproduce, and over generations those resistance genes dominate the population on your farm. We did this to ourselves through decades of well-intentioned over-treatment.

The good news is that ivermectin and moxidectin remain highly effective against strongyles in most populations — but they are not unlimited resources. We have a professional responsibility to preserve them. The modern approach, now endorsed by the American Association of Equine Practitioners (AAEP) and the European Scientific Counsel Companion Animal Parasites (ESCCAP), is targeted selective treatment based on fecal egg count monitoring.

Understanding Who Actually Needs Treatment

Here is something that surprises many horse owners: research consistently shows that in any given herd, approximately 20 to 30 percent of horses shed 80 percent of the parasite eggs. These are called “high shedders.” The majority of horses on your property are “low shedders” — they have natural immune regulation that keeps their parasite burdens low without your help. Treating low shedders every 6 to 8 weeks accomplishes almost nothing clinically while contributing massively to resistance development.

The targeted selective treatment (TST) approach identifies which animals actually need treatment, treats them appropriately, and spares the others. This preserves refugia — the population of drug-susceptible worms living in untreated horses and on pasture — which dilutes resistance genes in the overall population and slows the development of resistance.

The Fecal Egg Count: Your Primary Tool

A fecal egg count (FEC) measures the number of parasite eggs per gram (EPG) of feces. Your veterinarian can run this test in the clinic, or you can use a commercial mail-in service with validated McMaster or FLOTAC techniques. The test is inexpensive — typically $15 to $30 — and the information it provides is far more valuable than guessing.

Classification by shedder status:

• Low shedders: fewer than 200 EPG. These horses have good immune regulation. They typically need only 1 to 2 strategic treatments per year — targeting encysted cyathostomins in late autumn and potentially tapeworms depending on geographic risk.
• Moderate shedders: 200 to 500 EPG. These horses benefit from 2 to 3 treatments per year, timed to biology (treat in late spring after the periparturient period and in autumn).
• High shedders: above 500 EPG. These horses need 3 to 4 treatments per year and are the focus of your parasite management efforts. They may also benefit from pasture management strategies — harrowing and resting paddocks to kill larvae, picking up manure regularly.

FECs are most useful for strongyles and are not reliable for bots (Gasterophilus), tapeworms (Anoplocephala), or encysted small strongyles (hypobiotic larvae). These require different testing or strategic treatment approaches.

Checking Whether Your Drugs Still Work: The FECRT

The fecal egg count reduction test (FECRT) is how you confirm that the drugs you are using are actually effective on your property. The protocol is simple: perform a FEC before treatment, administer the drug, and repeat the FEC at 14 days (for most drugs) or 21 days (for moxidectin). Calculate the percentage reduction.

Efficacy benchmarks: a reduction of 95 percent or more indicates good efficacy. A reduction of 85 to 95 percent suggests possible early resistance. A reduction below 85 percent indicates resistance and that drug class should not be relied upon as your primary treatment on that farm. I recommend performing a FECRT at least once per property to establish a baseline, and repeating it every 2 to 3 years or if you suspect your program is failing.

The Drug Classes and What They Cover

Ivermectin

Ivermectin is effective against adult cyathostomins, large strongyles, ascarids in young horses, bots, and pinworms. It does not kill encysted cyathostomin larvae. It has a broad safety margin and is safe in most horses at labeled doses. In most regions, strongyle efficacy remains good, though ascarid resistance to ivermectin is now well-documented and foal deworming protocols should account for this.

Moxidectin

Moxidectin (Quest) has a longer activity period than ivermectin and has some efficacy against early fourth-stage encysted cyathostomin larvae, making it the preferred autumn treatment for encysted larvae in adult horses. Use it strategically, not routinely. It has a narrower safety margin and should never be used in foals under 4 months or in severely debilitated horses.

Benzimidazoles (Fenbendazole and Oxibendazole)

Historically important drug class, but widespread resistance in cyathostomins makes routine use unreliable without FECRT confirmation. A 5-day double dose of fenbendazole (PowerPac) was previously used for encysted larvae, but resistance has compromised this protocol in many populations. Confirm efficacy before relying on this class.

Pyrantel

Effective against adult strongyles and ascarids; some activity against tapeworms at double dose. Resistance is increasing but it remains useful in many populations. Daily pyrantel (Strongid C) was once popular for continuous prophylaxis but has accelerated resistance development and is no longer recommended.

Praziquantel

Praziquantel is the only reliable treatment for equine tapeworms (Anoplocephala perfoliata and Anoplocephala magna). It is typically combined with ivermectin or moxidectin in products like Equimax or Quest Plus. Tapeworm treatment is typically recommended once or twice yearly, in autumn and sometimes spring, particularly in areas where the oribatid mite intermediate host is present. Salivary antibody testing is now available to assess tapeworm exposure risk.

Building Your Program

Here is how I recommend structuring a modern program. In early spring, run FECs on all horses and classify shedders. Treat high and moderate shedders appropriately. In autumn — typically October to November in temperate regions — treat all adult horses for encysted cyathostomins with moxidectin, and include praziquantel for tapeworms. Young horses (under 3 years) and aged horses (over 15 with PPID) are higher-risk groups that warrant more frequent monitoring. Run a FECRT at least once to confirm drug efficacy on your property.

This approach uses fewer treatments, preserves drug efficacy, and focuses your resources where they actually matter. It is more scientific, more responsible, and ultimately better for your horses than the old calendar-based rotation ever was.